Technical Analysis for VNDA - Vanda Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade A 30.82 2.15% 0.65
VNDA closed up 2.15 percent on Thursday, January 17, 2019, on 88 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VNDA trend table...

Date Alert Name Type % Chg
Jan 17 Multiple of Ten Bullish Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 16 Pocket Pivot Bullish Swing Setup 2.15%
Jan 16 Multiple of Ten Bullish Other 2.15%
Jan 16 Overbought Stochastic Strength 2.15%
Jan 15 180 Bullish Setup Bullish Swing Setup 5.22%
Jan 15 Outside Day Range Expansion 5.22%
Jan 15 Overbought Stochastic Strength 5.22%

Older signals for VNDA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders. The company provides Fanapt, a compound for the treatment of schizophrenia; and VLY-686, a small molecule neurokinin-1 receptor (NK-1R) antagonist that has indications for chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, alcohol dependence, anxiety, depression, and pruritus. Its product in clinical development includes Tasimelteon, which completed Phase III clinical trials for the treatment of circadian rhythm sleep disorders, as well as completed Phase IIb/III trials for the treatment of major depressive disorder and insomnia. Vanda Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Washington, District of Columbia.
Is VNDA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.44
52 Week Low 13.88
Average Volume 721,497
200-Day Moving Average 20.7405
50-Day Moving Average 25.73
20-Day Moving Average 27.1565
10-Day Moving Average 28.993
Average True Range 1.384
ADX 27.52
+DI 29.0829
-DI 12.1968
Chandelier Exit (Long, 3 ATRs ) 26.908
Chandelier Exit (Short, 3 ATRs ) 27.322
Upper Bollinger Band 31.2848
Lower Bollinger Band 23.0282
Percent B (%b) 0.94
BandWidth 30.403771
MACD Line 1.2393
MACD Signal Line 0.9603
MACD Histogram 0.279
Fundamentals Value
Market Cap 1.38 Billion
Num Shares 44.9 Million
EPS -0.23
Price-to-Earnings (P/E) Ratio -134.00
Price-to-Sales 4.05
Price-to-Book 4.81
PEG Ratio -2.09
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.00
Resistance 3 (R3) 32.83 31.95 32.63
Resistance 2 (R2) 31.95 31.39 32.03 32.51
Resistance 1 (R1) 31.38 31.05 31.67 31.55 32.39
Pivot Point 30.50 30.50 30.64 30.58 30.50
Support 1 (S1) 29.93 29.94 30.22 30.10 29.25
Support 2 (S2) 29.05 29.60 29.13 29.13
Support 3 (S3) 28.48 29.05 29.01
Support 4 (S4) 28.65